Results 151 to 160 of about 2,363,412 (175)
Some of the next articles are maybe not open access.

Aspirin and aspirin resistance in coronary artery disease

Current Opinion in Pharmacology, 2013
Aspirin is still the mainstay of antiplatelet therapy in the secondary prevention of coronary artery disease. However certain patients do not benefit from the antithrombotic effects of aspirin. The phenomenon of so-called aspirin resistance can be considered from the clinical and laboratory perspective.
Charalampos, Kasmeridis   +2 more
openaire   +2 more sources

Aspirin resistance.

Pharmacological reports : PR, 2010
Aspirin protects many though not all patients from acute cardiovascular events. It is generally accepted that such prophylactic effect depends mainly on the antithrombotic action involving inhibition of thromboxane A(2) production and platelet aggregation.
Andrzej, Szczeklik   +4 more
openaire   +1 more source

Diagnostics for Aspirin Resistance

Molecular Diagnosis & Therapy, 2008
Paul A, Gurbel   +2 more
openaire   +2 more sources

Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome

Ca-A Cancer Journal for Clinicians, 2012
Mary Kay Barton
exaly  

Aspirin resistance: Effect of clinical, biochemical and genetic factors

Pharmacology & Therapeutics, 2011
Munir Pirmohamed, Richard Fitzgerald
exaly  

Pharmacogenetics of aspirin resistance: a comprehensive systematic review

British Journal of Clinical Pharmacology, 2008
Albert Ferro
exaly  

Aspirin Resistance in Cardiovascular Disease: A Review

European Journal of Vascular and Endovascular Surgery, 2004
D R Lewis, M Appleberg, D R Lewis
exaly  

Home - About - Disclaimer - Privacy